{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:13:12Z","timestamp":1782209592294,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jgeb.2024.100394","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T18:08:02Z","timestamp":1717610882000},"page":"100394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma"],"prefix":"10.1016","volume":"22","author":[{"given":"Khalda","family":"Sayed Amr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Mohamed Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ibrahim Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Heiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refaat","family":"Refaat Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Eltaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Henery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Omaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Ibrahim Siddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Abdelghany Abdelazeem Elhosary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jgeb.2024.100394_b0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","volume":"37","author":"Khan","year":"2002","journal-title":"J Hepatol."},{"issue":"10","key":"10.1016\/j.jgeb.2024.100394_b0010","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/carcin\/bgm177","article-title":"Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum","volume":"28","author":"Goldman","year":"2007","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.jgeb.2024.100394_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1386-6346(00)00105-4","article-title":"Prevalence and epidemiological features of hepatocellular carcinoma in Egypt\u2014a single centre experience","volume":"19","author":"El-Zayadi","year":"2001","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jgeb.2024.100394_b0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biopsych.2020.01.025","article-title":"Schizophrenia and epigenetic aging biomarkers: increased mortality, reduced cancer risk, and unique clozapine effects","volume":"88","author":"Higgins-Chen","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jgeb.2024.100394_b0025","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.7150\/ijbs.44024","article-title":"Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis andtherapeutic monitoring in hepatocellular carcinoma","volume":"16","author":"Wu","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2024.100394_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hep.31659","article-title":"DNA methylation profiling of human hepatocarcinogenesis","volume":"74","author":"Hernandez-Meza","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jgeb.2024.100394_b0035","doi-asserted-by":"crossref","unstructured":"Siyu Fu, Jos\u00e9 D. Debes, Andr\u00e9 Boonstra. DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer. 2023; 191; 112960. ISSN 0959-8049. doi.org\/10.1016\/j.ejca.2023.112960.","DOI":"10.1016\/j.ejca.2023.112960"},{"issue":"2","key":"10.1016\/j.jgeb.2024.100394_b0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.yexmp.2010.01.002","article-title":"Kiviat NB (2010): DNA Methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection","volume":"88","author":"Feng","year":"2010","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"10.1016\/j.jgeb.2024.100394_b0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.22110","article-title":"Aberrant methylation of multiple tumour suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma","volume":"47","author":"Nishida","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jgeb.2024.100394_b0050","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.31557\/APJCP.2020.21.11.3357","article-title":"DNA methyltransferases as po-tential biomarkers for HCV related hepatocellular carcinoma","volume":"21","author":"Hassouna","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"22","key":"10.1016\/j.jgeb.2024.100394_b0055","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1038\/onc.2013.225","article-title":"Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesench-ymal transition","volume":"33","author":"Quan","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jgeb.2024.100394_b0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.canlet.2013.02.057","article-title":"Hepatitis C virus core protein overcomes all-trans retinoic acid- induced cell growth arrest by inhibiting retinoic acid receptor- beta2 expression via DNA methylation","volume":"335","author":"Lee","year":"2013","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"10.1016\/j.jgeb.2024.100394_b0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virusres.2011.05.014","article-title":"(2011): Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein","volume":"160","author":"Ripoli","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.jgeb.2024.100394_b0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","article-title":"The role of DNA methylation in cancer","volume":"945","author":"Lakshminarasimhan","year":"2016","journal-title":"Adv Experiment Med Biol"},{"key":"10.1016\/j.jgeb.2024.100394_b0075","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jgeb.2024.100394_b0080","unstructured":"- World Health Organisation, News room, fact sheets, cancer. In: WHO [Internet]. 1 Feb 2018 [cited 6 May 2018]. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"issue":"49","key":"10.1016\/j.jgeb.2024.100394_b0085","doi-asserted-by":"crossref","first-page":"81255","DOI":"10.18632\/oncotarget.13221","article-title":"Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgeb.2024.100394_b0090","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-06-3464","article-title":"Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis","volume":"67","author":"Nishida","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgeb.2024.100394_b0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2350-14-14","article-title":"The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma","volume":"14","author":"Ling","year":"2013","journal-title":"BMC Med Genet."},{"key":"10.1016\/j.jgeb.2024.100394_b0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9440(10)63469-4","article-title":"Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma","volume":"163","author":"Yang","year":"2003","journal-title":"Am H Pathol."},{"key":"10.1016\/j.jgeb.2024.100394_b0105","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s12253-019-00612-5","article-title":"SOCS1 and its Potential Clinical Role in Tumor","volume":"25","author":"Ying","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jgeb.2024.100394_b0110","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4161\/cc.7.20.6816","article-title":"Epigenetic down-regulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats","volume":"7","author":"Bagnyukova","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jgeb.2024.100394_b0115","doi-asserted-by":"crossref","unstructured":"Yoshida T, Ogata H, Kamio M, et al. SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis. J Exp Med [Internet]. 2004 Jun 6 [cited 2023 Aug 18];199(12):1701. Available from: \/pmc\/articles\/PMC2212816\/.","DOI":"10.1084\/jem.20031675"},{"issue":"10","key":"10.1016\/j.jgeb.2024.100394_b0120","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/diagnostics11101825","article-title":"The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma","volume":"11","author":"Cabral","year":"2021","journal-title":"Diagnostics."},{"issue":"14","key":"10.1016\/j.jgeb.2024.100394_b0125","first-page":"5295","article-title":"Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis","volume":"9","author":"Okochi","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jgeb.2024.100394_b0130","article-title":"Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma","volume":"140","author":"Chu","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jgeb.2024.100394_b0135","first-page":"142","article-title":"Aberrant promoter methylation of SOCS-1 gene may contribute to the pathogenesis of hepatocellular carcinoma: A meta-analysis. J. BU ON","volume":"21","author":"Zhao","year":"2016","journal-title":"Off. J. Balk. Union Oncol."},{"key":"10.1016\/j.jgeb.2024.100394_b0140","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/diagnostics11101825","article-title":"The relevance of SOCS1 methylation and epigenetic therapy in diverse cell populations of hepatocellular carcinoma","volume":"11","author":"Cabral","year":"2021","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.jgeb.2024.100394_b0145","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jgeb.2024.100394_b0150","doi-asserted-by":"crossref","unstructured":"Khan MGM, Ghosh A, Variya B, et al. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma. BMC Cancer [Internet]. 2020 Aug 17 [cited 2023 Aug 18];20(1):1\u201318. Available from: https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07285-3.","DOI":"10.1186\/s12885-020-07285-3"},{"key":"10.1016\/j.jgeb.2024.100394_b0155","article-title":"Family history of colorectal or oesophageal cancer in barrett's oesophagus and potentially explanantory genetic variants","volume":"1194","author":"Rubenstein","year":"2020","journal-title":"Clin Transl Gastroeneterol."},{"issue":"9","key":"10.1016\/j.jgeb.2024.100394_b0160","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/cells8091084","article-title":"Effect of adenomatous polyposis coli loss on tumorigenic potential in pancreatic ductal adenocarcinoma","volume":"8","author":"Cole","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.jgeb.2024.100394_b0165","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)63495-5","article-title":"Aberrrant CpG island hypermethylation along multistep hepatocarcinogenesis","volume":"163","author":"Lee","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jgeb.2024.100394_b0170","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0002-9440(10)63469-4","article-title":"Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma","volume":"163","author":"Yang","year":"2003","journal-title":"Am H Pathol."},{"issue":"5","key":"10.1016\/j.jgeb.2024.100394_b0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00432-007-0321-y","article-title":"APC promoter methylation and protein expression in hepatocellular carcinoma","volume":"134","author":"Csepregi","year":"2008","journal-title":"J Cancer Res Clin Oncol."},{"issue":"21","key":"10.1016\/j.jgeb.2024.100394_b0180","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.3390\/ijms21217844","article-title":"Wnt-independent and Wnt-dependent effects of APC loss on the chemotherapeutic response","volume":"21","author":"Stefanski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jgeb.2024.100394_b0185","article-title":"APC Promoter Methylation in Gastrointestinal Cancer","volume":"11","author":"Zhu","year":"2021","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.jgeb.2024.100394_b0190","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/carcin\/bgn179","article-title":"Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells","volume":"29","author":"Xiang","year":"2008","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.jgeb.2024.100394_b0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/gcc.22154","article-title":"Genistein inhibitis DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells","volume":"53","author":"Xie","year":"2014","journal-title":"Genes Chromosom Cancer."},{"key":"10.1016\/j.jgeb.2024.100394_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcp.10140","article-title":"GADD45b and GADD45g are cdc2\/cyclinB1 kinase inhibitors with a role in S and G2\/M cell cycle checkpoints induced by genotoxic stress","volume":"192","author":"Vairapandi","year":"2002","journal-title":"J Cell Physiol"},{"issue":"24","key":"10.1016\/j.jgeb.2024.100394_b0205","doi-asserted-by":"crossref","first-page":"37215","DOI":"10.18632\/oncotarget.9295","article-title":"GADD45\u03b2 induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.jgeb.2024.100394_b0210","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63425-6","article-title":"Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 \u0152\u2264 Promoter in Human Hepatocellular Carcinoma","volume":"165","author":"Qiu","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jgeb.2024.100394_b0215","unstructured":"Roncalli M, Bianchi P, Bruni B, et al. Methylation framework of cell cycle gene inhibitors in cirrhosis."},{"issue":"2","key":"10.1016\/j.jgeb.2024.100394_b0220","doi-asserted-by":"crossref","DOI":"10.2174\/138920211795564359","article-title":"Genetic and epigenetic signatures in human hepatocellular carcinoma: A systematic review","volume":"12","author":"Nishida","year":"2011","journal-title":"Curr Genomics"},{"key":"10.1016\/j.jgeb.2024.100394_b0225","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1478-3231.2007.01499.x","article-title":"P21\/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection","volume":"27","author":"Kao","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jgeb.2024.100394_b0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-5793(02)02694-7","article-title":"Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein","volume":"518","author":"Han","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jgeb.2024.100394_b0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.510300114","article-title":"Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence","volume":"30","author":"Ito","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jgeb.2024.100394_b0240","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.3748\/wjg.v11.i29.4587","article-title":"Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis","volume":"11","author":"Lei","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.jgeb.2024.100394_b0245","first-page":"6901","article-title":"The anti-hepatocellular carcinoma activity of Mel-P15 is mediated by natural killer cells","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jgeb.2024.100394_b0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12935-018-0629-5","article-title":"DNA methylation biomarkers for hepatocellular carcinoma","volume":"18","author":"Fan","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"9","key":"10.1016\/j.jgeb.2024.100394_b0255","first-page":"3516","article-title":"Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients","volume":"6","author":"Wong Ivy","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jgeb.2024.100394_b0260","doi-asserted-by":"crossref","unstructured":"Fang D, Guo Y, Zhu Z, Chen W. Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells. Bosnian journal of basic medical sciences \/ Udru\u017eenje basi\u010dnih mediciniskih znanosti = Association of Basic Medical Sciences. 2012; 12: 4-9. 10.17305\/bjbms.2012.2523.","DOI":"10.17305\/bjbms.2012.2523"},{"issue":"39","key":"10.1016\/j.jgeb.2024.100394_b0265","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","article-title":"Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival","volume":"22","author":"Muratovska","year":"2003","journal-title":"Oncogene."},{"key":"10.1016\/j.jgeb.2024.100394_b0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13148-016-0208-3","article-title":"Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma","volume":"8","author":"Shih","year":"2016","journal-title":"Clin Epigenet"},{"issue":"12","key":"10.1016\/j.jgeb.2024.100394_b0275","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1515\/cclm-2015-1198","article-title":"Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma","volume":"54","author":"M\u017eik","year":"2016","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"10.1016\/j.jgeb.2024.100394_b0280","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cellsig.2006.09.003","article-title":"STAT1 as a key modulator of cell death","volume":"19","author":"Kim","year":"2007","journal-title":"Cell Signal."},{"key":"10.1016\/j.jgeb.2024.100394_b0285","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3892\/or.2013.2398","article-title":"STAT1 negatively regulates hepatocellular carcinoma cell proliferation","volume":"29","author":"Chen","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.jgeb.2024.100394_b0290","doi-asserted-by":"crossref","first-page":"e84453","DOI":"10.1371\/journal.pone.0084453","article-title":"Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon ofAdvanced-Stage HCCs","volume":"9","author":"Hinrichsen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgeb.2024.100394_b0295","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-15-2926","article-title":"MSH2 dysregulation is triggered by proinflammatory cytokine stimulation and is associated with liver cancer development","author":"Eso","year":"2016","journal-title":"Cancer Res"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X24000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X24000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T03:10:29Z","timestamp":1724555429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X24000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1687157X24000970"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2024.100394","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2024.100394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100394"}}